Use of Anti-TNF α Agents (Infliximab and Etanercept) in Rheumatoid Arthritis and Ankylosing Spondylitis: Experience of a Rheumatology Practice at Apollo Hospitals, India

Dougados, 1991, The European Spondyloarthropathy Study Group preliminary criteria for Spondyloarthropathy, Arthritis Rheum, 34, 1218, 10.1002/art.1780341003 Dougados, 1986, Sulphasalazine in ankylosing spondylitis: a double blind, controlled study in 60 patients, Br Med J, 293, 911, 10.1136/bmj.293.6552.911 Upadhyaya, 2004, Low dose methotrexate in seronegative spondyloarthropathy: result of a double blind, placebo controlled trial, J Indian Rheumatol Assoc, 12, 6 Goekoop, 2001, Combination therapy in rheumatoid arthritis, Curr Opin Rheumatol, 13, 177, 10.1097/00002281-200105000-00005 Taylor, 2001, Anti-tumor necrosis factor therapies, Curr Opin Rheumatol, 13, 164, 10.1097/00002281-200105000-00003 Braun, 1995, Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis, Arthritis Rheum, 38, 499, 10.1002/art.1780380407 Filip, 2003, Rheum Dis Clin N Am, 29, 463, 10.1016/S0889-857X(03)00052-8 Mease, 2000, Etanercept in the treatment of psoritic arthritis and psoriasis: a randomized trial, Lancet, 356, 385, 10.1016/S0140-6736(00)02530-7 Van den Bosch, 2000, Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms, Lancet, 356, 1821, 10.1016/S0140-6736(00)03239-6 Elliot, 1993, Treatment of rheumatoid arthritis with chimeric monoclonal antibody to tumor necrosis factor a, Arthritis Rheum, 36, 1681, 10.1002/art.1780361206 Elliot MJ, Maini RN, Feldmann M, et al. Repeated therapy with monoclonal antibody to tumor necrosis factor a. (cA2) in patients with rheumatoid arthritis. Fatima, 2004, Biologic Response Modifiers, J Indian Rheumatol Assoc, 12, 16